نتائج البحث

1

تقرير

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

المصدر: A Randomized Study of Two Dosing Regimens of Adagrasib in Patients With Previously Treated Non-Small Cell Lung Cancer With KRAS G12C Mutation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05853575Test

View record in ClinicalTrials.gov

2

تقرير

Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)

المؤلفون: Aadi Bioscience, Inc.

المصدر: A Phase 1/2 Trial of Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05840510Test

View record in ClinicalTrials.gov

3

تقرير

Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

المصدر: A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05737706Test

View record in ClinicalTrials.gov

4

تقرير

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

المصدر: A Phase 2 Trial of Combination Therapies With Adagrasib in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05609578Test

View record in ClinicalTrials.gov

5

تقرير

A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway

المصدر: A Phase 1/2 Multiple Expansion Cohort Trial of the SOS1 Inhibitor MRTX0902 in Patients With Advanced Solid Tumors Harboring Mutations in the KRAS MAPK Pathway

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05578092Test

View record in ClinicalTrials.gov

6

تقرير

Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion

المصدر: A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With Homozygous MTAP Deletion

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05245500Test

View record in ClinicalTrials.gov

7

تقرير

Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16)

المصدر: A Phase 1/1b Trial of MRTX849 in Combination With Palbociclib in Patients With Advanced Solid Tumors With KRAS G12C Mutation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05178888Test

View record in ClinicalTrials.gov

8

تقرير

Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation

المصدر: Expanded Access Use of Adagrasib (MRTX849) for the Treatment of Patients With Advanced Solid Tumors With a KRAS G12C Mutation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05162443Test

View record in ClinicalTrials.gov

9

تقرير

Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)

المؤلفون: Boehringer Ingelheim

المصدر: A Phase 1/1b Trial of MRTX849 in Combination With BI 1701963 in Patients With Advanced Solid Tumors With KRAS G12C Mutation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04975256Test

View record in ClinicalTrials.gov

10

تقرير

Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study

المصدر: A Multicenter, Open-label Rollover Study of Sitravatinib Alone or in Combination With Other Anticancer Therapies in Patients With Advanced or Metastatic Solid Malignancies

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04887870Test

View record in ClinicalTrials.gov

تنقيح النتائج